Jay Hartenbach
Tracked across 1 events · 6 articles · First seen May 29, 2026 · Last active May 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jay Hartenbach, President and COO of Diakonos Oncology, commented on the benefits of using Natera's Signatera test in the DOC-RM trial.
May 29, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jay Hartenbach live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard